ArriVent BioPharma Inc.
AVBP | NASDAQ
$29.98
+$0.24 (+0.81%)
Sep 22, 2026, 10:26 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -9.44 | -6.54 | -4.50 | -4.35 | -5.42 | -4.90 | -11.15 | -9.75 | -8.14 | -8.25 | -9.71 | -11.49 | -12.05 | -2.95 | -1.64 | -1.68 | -932.06M | -1Qu |
PEG Ratio | -1.01 | -0.46 | -3.74 | 0.56 | 0.10 | -0.02 | n/a | 1.58 | -0.33 | 0.47 | -0.21 | 0.35 | -0.15 | -0.18 | 0.14 | 0.02 | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.51 | 3.21 | 2.52 | 2.54 | 3.05 | 3.09 | 3.47 | 2.84 | 2.05 | 1.93 | 4.43 | 3.90 | 3.60 | 3.84 | 3.84 | n/a | n/a | 0.62 |
P/FCF Ratio | -11.18 | -7.73 | -4.82 | -5.29 | -6.02 | -5.24 | -12.74 | -11.44 | -8.93 | -10.65 | -12 | -11.79 | -13.06 | -15.69 | -25.95 | -67.49 | n/a | n/a |
P/OCF Ratio | -11.18 | -7.73 | -4.82 | -5.29 | -6.02 | -5.24 | -12.74 | -11.44 | -8.93 | -10.65 | -12 | -11.79 | -13.06 | -15.69 | -25.95 | -67.49 | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n/a | 0 | n/a | n/a | n/a |
Quick Ratio | 14.16 | 13.95 | 12.83 | 14.90 | 12.74 | 14.34 | 13.14 | 19.28 | 25.50 | 32.82 | 13.76 | 17.82 | 15.51 | n/a | 21.84 | n/a | n/a | n/a |
Current Ratio | 14.16 | 13.95 | 12.83 | 14.90 | 12.74 | 14.34 | 13.14 | 19.28 | 25.50 | 32.82 | 13.76 | 17.82 | 15.51 | n/a | 21.84 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -13.60% | -13.37% | -11.57% | -11.47% | -12.57% | -31.79% | -8.01% | -7.41% | -7.37% | -5.48% | -14.01% | -8.38% | -11.59% | -6.98% | -5.99% | n/a | n/a | -17.83% |
Return on Assets | -12.64% | -12.40% | -10.67% | -10.71% | -11.65% | -29.88% | -7.50% | -7.03% | -7.08% | -5.31% | -12.99% | -7.91% | -10.85% | n/a | -5.71% | n/a | n/a | n/a |
Return on Invested Capital | -14.35% | -14.21% | -12.64% | -12.56% | -13.45% | -32.94% | -9.19% | -8.72% | -8.65% | -6.50% | -15.25% | -9.72% | -12.13% | n/a | -5.98% | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AVBP